Download
12865_2024_Article_674.pdf 1,77MB
WeightNameValue
1000 Titel
  • Phenotypic characterization of NK cells in 5-year-old children exposed to maternal HIV and antiretroviral therapy in early-life
1000 Autor/in
  1. Mataramvura, Hope |
  2. Jӓger, Julia |
  3. Jordan-Paiz, Ana |
  4. Mazengera, Lovemore Ronald |
  5. Gumbo, Felicity Zvanyadza |
  6. Bunders, Madeleine J. |
  7. Duri, Kerina |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-12-19
1000 Erschienen in
1000 Quellenangabe
  • 25(1):82
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12865-024-00674-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11658373/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>HIV-exposed uninfected (HEU) children are at increased risk of morbidity during the first years of life. Although the immune responses of HEU infants in early-life are relatively well described, studies of natural killer (NK) cells in older HEU children are lacking. NK cell subsets were analysed in HEU children and compared to those in HIV unexposed uninfected (HUU) children aged ~ five years.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Multi-parametric flow cytometry was used to characterize peripheral blood-derived NK cell CD56, CD16, CD57, NKG2A and KIR3DL1/KIR2DL2/L3 expression, including intracellular perforin and granzyme B. NK cell subsets were compared between HEU children exposed to prenatal antiretroviral therapy (ART) from conception [long-term (HEULT)]; those exposed to ART during pregnancy [medium-term (HEUMT)] with continued exposure throughout the breastfeeding period and HUU peers. Furthermore, clinical data of the children, including sick clinic visits and hospitalizations documented in morbidity diaries from birth to 5 years were compared between HEU and HUU groups. Frequencies of CD56<jats:sup>bright</jats:sup> and CD56<jats:sup>dim</jats:sup> NK cell were correlated with these clinical parameters.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>139 children were enrolled however, 133 comprising 43 HEULT, 38 HEUMT and 52 HUU were included in the main analyses. Total NK cell, CD56<jats:sup>bright</jats:sup> nor CD56<jats:sup>dim</jats:sup> NK cell proportions differed between HEU and HUU children. However, HEULT children had lower frequencies of CD56<jats:sup>dim</jats:sup> NK cells compared to HEUMT children, (<jats:italic>p</jats:italic> = 0.002) which maintained significance after controlling for preterm birth, <jats:italic>p</jats:italic> = 0.012. No differences were observed between HEULT and HUU. The expressions of NKG2A, KIR3DL1/KIR2DL2/L3 and CD57 on CD56<jats:sup>bright</jats:sup> and CD56<jats:sup>dim</jats:sup> NK cells were similar between the three groups. Furthermore, the frequencies of granzyme B and perforin double positive NK cells were similar between the HUU with HEULT and HEUMT children. CD56<jats:sup>dim</jats:sup> NK cell counts had a significant moderate negative correlation with recurrent respiratory infections (rho=-0.38; <jats:italic>p</jats:italic> = 0.010) in HUU children and negatively correlated with total sick clinic visits in HEUMT (rho=-0.40, <jats:italic>p</jats:italic> = 0.064).</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>The proportions of total NK cell, CD56<jats:sup>bright</jats:sup> and CD56<jats:sup>dim</jats:sup> NK cells, NK cells inhibitory and differentiation surface marker expression and cytolytic granule-positive cells were similar between HEU and HUU children. These data suggest that early-life HIV/ART exposure may not result in major changes in NK cell subsets at 5 years of age.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Infant, Newborn [MeSH]
lokal Morbidity in a low resource setting
lokal CD56
lokal NK cell inhibitory markers
lokal Anti-Retroviral Agents/therapeutic use [MeSH]
lokal HIV-1/immunology [MeSH]
lokal CD56 Antigen/metabolism [MeSH]
lokal Perforin and granzyme B
lokal Early-life maternal HIV exposure
lokal Infant [MeSH]
lokal Male [MeSH]
lokal Immunophenotyping [MeSH]
lokal Killer Cells, Natural/immunology [MeSH]
lokal Prenatal Exposure Delayed Effects/immunology [MeSH]
lokal Pregnancy Complications, Infectious/immunology [MeSH]
lokal Female [MeSH]
lokal Perforin/metabolism [MeSH]
lokal Cellular immunology and HIV
lokal Granzymes/metabolism [MeSH]
lokal HIV Infections/immunology [MeSH]
lokal Humans [MeSH]
lokal Receptors, KIR3DL1/metabolism [MeSH]
lokal Children
lokal HIV Infections/drug therapy [MeSH]
lokal Preconception/post-conception antiretroviral therapy exposures
lokal Research
lokal Pregnancy Complications, Infectious/drug therapy [MeSH]
lokal Pregnancy [MeSH]
lokal Child, Preschool [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TWF0YXJhbXZ1cmEsIEhvcGU=|https://frl.publisso.de/adhoc/uri/StOTZ2VyLCBKdWxpYQ==|https://frl.publisso.de/adhoc/uri/Sm9yZGFuLVBhaXosIEFuYQ==|https://frl.publisso.de/adhoc/uri/TWF6ZW5nZXJhLCBMb3ZlbW9yZSBSb25hbGQ=|https://frl.publisso.de/adhoc/uri/R3VtYm8sIEZlbGljaXR5IFp2YW55YWR6YQ==|https://frl.publisso.de/adhoc/uri/QnVuZGVycywgTWFkZWxlaW5lIEou|https://frl.publisso.de/adhoc/uri/RHVyaSwgS2VyaW5h
1000 Hinweis
  • DeepGreen-ID: 2d4cbf9035f64b7c8c49bce36b5f428c ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search) ;
1000 Label
1000 Förderer
  1. Deutsche Forschungsgemeinschaft |
  2. Wellcome Trust |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Deutsche Forschungsgemeinschaft |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Wellcome Trust |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6521209.rdf
1000 Erstellt am 2025-07-06T06:16:19.023+0200
1000 Erstellt von 322
1000 beschreibt frl:6521209
1000 Zuletzt bearbeitet 2025-08-04T09:20:54.229+0200
1000 Objekt bearb. Mon Aug 04 09:20:54 CEST 2025
1000 Vgl. frl:6521209
1000 Oai Id
  1. oai:frl.publisso.de:frl:6521209 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source